ea0078cme4.2 | Session 4 | BSPED2021
McCrimmon Rory
The discovery of insulin and its subsequent mass manufacture transformed the lives of people with type 1 diabetes. Insulin replacement is not, however, without risk and it soon emerged that many individuals with type 1 diabetes experienced iatrogenic hypoglycaemia. Hypoglycaemia in type 1 diabetes has both immediate (cognitive impairment) and longer-term consequences. In this presentation I will focus on the longer-term consequences of recurrent hypoglycaemia and in particular...